Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease

NCT00034645 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Mycoses

Interventions

DRUG: Posaconazole oral suspension

Sponsor

Merck Sharp & Dohme LLC